Literature DB >> 15672553

Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder.

Jessie S Chambers1, Nora I Perrone-Bizzozero.   

Abstract

Myelination of the frontal and temporal lobes occurs at a similar time period as symptom onset in schizophrenia. To assess this potential relationship, we compared myelination and oligodendrocyte numbers in the hippocampal formation of controls and matched subjects with schizophrenia and bipolar disorder. The levels and distribution of the myelin marker myelin basic protein (MBP) and the oligodendrocyte marker adenomatous polyposis coli (APC) were measured using immunocytochemistry. MBP immunoreactivity (IR) was increased in several hippocampal subregions of control females versus control males. Female subjects with schizophrenia and bipolar disorder exhibited decreased myelination in the hippocampal formation while male subjects with bipolar disorder showed increased MBP levels in the superior medullary lamina. In contrast, the number of APC immunoreactive cells did not differ in any disorder or region. Our results demonstrate an interaction between gender, mental illness, and myelination, and may be related to cognitive deficits seen in schizophrenia and bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15672553     DOI: 10.1007/s11064-004-7039-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  68 in total

1.  Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders.

Authors:  M J Webster; M B Knable; J O'Grady; J Orthmann; C S Weickert
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

2.  Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls.

Authors:  T D Cannon; T G van Erp; M Huttunen; J Lönnqvist; O Salonen; L Valanne; V P Poutanen; C G Standertskjöld-Nordenstam; R E Gur; M Yan
Journal:  Arch Gen Psychiatry       Date:  1998-12

Review 3.  Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms.

Authors:  N C Andreasen; P Nopoulos; D S O'Leary; D D Miller; T Wassink; M Flaum
Journal:  Biol Psychiatry       Date:  1999-10-01       Impact factor: 13.382

4.  The effects of corticosteroids on myelination of the developing rat brain.

Authors:  M Gumbinas; M Oda; P Huttenlocher
Journal:  Biol Neonate       Date:  1973

5.  Flash visual evoked potentials in the hypomyelinated mutant mouse shiverer.

Authors:  Donna M Lehman; Joseph M Harrison
Journal:  Doc Ophthalmol       Date:  2002-01       Impact factor: 2.379

6.  Learning and forgetting in schizophrenia.

Authors:  J M Gold; G Rehkemper; S W Binks; C J Carpenter; K Fleming; T E Goldberg; D R Weinberger
Journal:  J Abnorm Psychol       Date:  2000-08

7.  Notch receptor activation inhibits oligodendrocyte differentiation.

Authors:  S Wang; A D Sdrulla; G diSibio; G Bush; D Nofziger; C Hicks; G Weinmaster; B A Barres
Journal:  Neuron       Date:  1998-07       Impact factor: 17.173

Review 8.  White matter changes in schizophrenia: evidence for myelin-related dysfunction.

Authors:  Kenneth L Davis; Daniel G Stewart; Joseph I Friedman; Monte Buchsbaum; Philip D Harvey; Patrick R Hof; Joseph Buxbaum; Vahram Haroutunian
Journal:  Arch Gen Psychiatry       Date:  2003-05

9.  Impaired hippocampal recruitment during normal modulation of memory performance in schizophrenia.

Authors:  Anthony P Weiss; Daniel L Schacter; Donald C Goff; Scott L Rauch; Nathaniel M Alpert; Alan J Fischman; Stephan Heckers
Journal:  Biol Psychiatry       Date:  2003-01-01       Impact factor: 13.382

10.  Myelin-specific proteins and glycolipids in rat Schwann cells and oligodendrocytes in culture.

Authors:  R Mirsky; J Winter; E R Abney; R M Pruss; J Gavrilovic; M C Raff
Journal:  J Cell Biol       Date:  1980-03       Impact factor: 10.539

View more
  37 in total

1.  Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancy.

Authors:  Andrew C Eschenroeder; Allison A Vestal-Laborde; Emilse S Sanchez; Susan E Robinson; Carmen Sato-Bigbee
Journal:  Glia       Date:  2011-10-14       Impact factor: 7.452

2.  Reduced white matter integrity and verbal fluency impairment in young adults with bipolar disorder: a diffusion tensor imaging study.

Authors:  Isabelle E Bauer; Austin Ouyang; Benson Mwangi; Marsal Sanches; Giovana B Zunta-Soares; Richard S E Keefe; Hao Huang; Jair C Soares
Journal:  J Psychiatr Res       Date:  2015-02-07       Impact factor: 4.791

3.  Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia.

Authors:  George Bartzokis; Po H Lu; Erika P Raven; Chetan P Amar; Nicole R Detore; Alexander J Couvrette; Jim Mintz; Joseph Ventura; Laurie R Casaus; John S Luo; Kenneth L Subotnik; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2012-07-17       Impact factor: 4.939

4.  Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia.

Authors:  George Bartzokis; Po H Lu; Keith H Nuechterlein; Michael Gitlin; Clarissa Doi; Nancy Edwards; Christopher Lieu; Lori L Altshuler; Jim Mintz
Journal:  Schizophr Res       Date:  2007-04-03       Impact factor: 4.939

5.  Neuron-specific Enolase and myelin basic protein in cerebrospinal fluid of patients with first episode schizophrenia.

Authors:  Shuying Li; Hanrong Wu; Huirong Guo; Zheng Zhao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

6.  Golli Myelin Basic Proteins Modulate Voltage-Operated Ca(++) Influx and Development in Cortical and Hippocampal Neurons.

Authors:  V T Cheli; D A Santiago González; V Spreuer; V Handley; A T Campagnoni; P M Paez
Journal:  Mol Neurobiol       Date:  2015-10-26       Impact factor: 5.590

7.  In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia.

Authors:  George Bartzokis; Po H Lu; Stephanie B Stewart; Bolanle Oluwadara; Andrew J Lucas; Joanna Pantages; Erika Pratt; Jonathan E Sherin; Lori L Altshuler; Jim Mintz; Michael J Gitlin; Kenneth L Subotnik; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2009-07-17       Impact factor: 4.939

8.  Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder.

Authors:  Lara G Chepenik; Carolyn Fredericks; Xenophon Papademetris; Linda Spencer; Cheryl Lacadie; Fei Wang; Brian Pittman; James S Duncan; Lawrence H Staib; Ronald S Duman; Joel Gelernter; Hilary P Blumberg
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

9.  Bisphenol-A impairs myelination potential during development in the hippocampus of the rat brain.

Authors:  Shashi Kant Tiwari; Swati Agarwal; Lalit Kumar Singh Chauhan; Vijay Nath Mishra; Rajnish Kumar Chaturvedi
Journal:  Mol Neurobiol       Date:  2014-08-02       Impact factor: 5.590

Review 10.  Convergence and divergence in the etiology of myelin impairment in psychiatric disorders and drug addiction.

Authors:  Yue Feng
Journal:  Neurochem Res       Date:  2008-04-11       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.